Udayavni Special

Nasal Covid vaccine prevents disease, transmission in animals: Study


Team Udayavani, Jul 12, 2021, 12:05 PM IST

Credit: Getty Images

Washington: A new single-dose, intranasal COVID-19 vaccine fully protects mice against lethal infection, and also blocks transmission of the SARS-CoV-2 virus in ferrets, a study has shown.

The new vaccine, described in the journal Science Advances, is administered through a nasal spray similar to those commonly used to vaccinate against influenza.

This new method is unlike the currently approved COVID-19 vaccines that require an injection.

“The currently available vaccines against COVID-19 are very successful, but the majority of the world”s population is still unvaccinated and there is a critical need for more vaccines that are easy to use and effective at stopping disease and transmission,” said Paul McCray, a professor of at University of Georgia, US.

“If this new COVID-19 vaccine proves effective in people, it may help block SARS-CoV-2 transmission and help control the COVID-19 pandemic,” McCray, co-leader of the study, said.

The researchers noted that the vaccine only requires a single dose and it may be stored at normal refrigerator temperatures for up to at least three months.

Because it is given intranasally, the vaccine may also be easier to administer, especially for those who have a fear of needles, they said.

“Our preclinical data show that this vaccine not only protects against infection, but also significantly reduces the chances of transmission,” said Biao He, a professor at the University of Georgia, and co-leader of the study.

The experimental vaccine uses a harmless parainfluenza virus 5 (PIV5) to deliver the SARS-CoV-2 spike protein into cells where it prompts an immune response that protects against COVID-19 infection.

PIV5 is related to common cold viruses and easily infects different mammals, including humans, without causing significant disease.

Spike protein helps the virus to enter and infect human cells, and vaccines are directed against it.

The team has previously shown that this vaccine platform can completely protect experimental animals from another dangerous coronavirus disease called Middle Eastern Respiratory Syndrome (MERS).

The inhaled PIV5 vaccine targets mucosal cells that line the nasal passages and airways, which are the main entry point for most SARS-CoV-2 infections and the site of early virus reproduction.

Virus produced in these cells can invade deeper into the lungs and other organs in the body, which can lead to more severe disease, according to the researchers.

Virus made in these cells can be easily shed through exhalation allowing transmission from one infected person to others, they said.

The study showed that the vaccine produced a localised immune response, involving antibodies and cellular immunity, that completely protected mice from fatal doses of SARS-CoV-2.

The vaccine also prevented infection and disease in ferrets and appeared to block transmission of COVID-19 from infected ferrets to their unprotected and uninfected cage-mates, the researchers added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

UK lifts quarantine for fully vaccinated EU, US travellers

Devdutt, Ruturaj among four debutants as Covid-hit India bat first against Sri Lanka

Finmin announces contest for new DFI name, tagline and logo; Rs 5 lakh reward for each component

16 security personnel killed during counter-terror operations on Indo-Pak border till June this year: Govt

DRDO to get 2 pc royalty from Dr Reddy’s on sale of anti-Covid drug 2-DG in India: Govt

Is PWD willing to construct elephant protection wall at Aralam: Ker HC asks state

New CM announces scholarship programme for ryots’ kids, hike in pension for senior citizens


Related Articles More

Swimming gives your brain a boost – but scientists don’t know yet why it’s better than other aerobic activities

Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study

Early antiviral response in nose may determine severity of COVID-19: Study

Over 3.09 crore unutilised vaccine doses available with states, private hospitals:Centre

PM Modi acclaimed DK district’s ‘Bakahu’ on his radio show recently; here’s what it is and how to make it?

MUST WATCH

Vandana Rai Karkala and her innovative teachings

Kiccha Sudeep Congratulate Karnataka new CM Basavaraj bommai

SHIFTING TO A VILLAGE HOTEL FROM A IT JOB

Basavaraj bommai family celebration

Pregnent lady may get Covid vaccine : Actress Chaitra rai

Latest Additions

UK lifts quarantine for fully vaccinated EU, US travellers

Devdutt, Ruturaj among four debutants as Covid-hit India bat first against Sri Lanka

Finmin announces contest for new DFI name, tagline and logo; Rs 5 lakh reward for each component

16 security personnel killed during counter-terror operations on Indo-Pak border till June this year: Govt

DRDO to get 2 pc royalty from Dr Reddy’s on sale of anti-Covid drug 2-DG in India: Govt

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.